AGTR1 and diabetic retinopathy: Prorenin was reported to directly activate cultured microglia, even when they were preincubated with an angiotensin II type 1 receptor blocker [36, 37], indicating that angiotensin II blockade is not sufficient to suppress microglial activation in diabetic retinopathy.